🔗 Share this article

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Thriving Trade on Social Networks

Separately, a robust market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers market the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Marketing retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Activities

Research also found groups with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, populated with images of slimming results, positive testimonials and detailed guides for mixing or administering at residence.

Within minutes of entering one group, a seller posted contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Pricing

Within these groups, posts show dark colored parcels with postal service stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20 milligrams. When asked how long a injector should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was clean,” she said.

Her team has already encountered patients harmed by self-injection from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may expose patients to possibly significant medical dangers”.